1SAN Stock Overview
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Sanofi Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €91.00 |
52 Week High | €105.00 |
52 Week Low | €80.75 |
Beta | 0.44 |
1 Month Change | 2.34% |
3 Month Change | 1.69% |
1 Year Change | -8.58% |
3 Year Change | 8.17% |
5 Year Change | 15.85% |
Change since IPO | 15.19% |
Recent News & Updates
Recent updates
Shareholder Returns
1SAN | IT Pharmaceuticals | IT Market | |
---|---|---|---|
7D | 3.7% | 0.7% | 1.3% |
1Y | -8.6% | 12.3% | 25.2% |
Return vs Industry: 1SAN underperformed the Italian Pharmaceuticals industry which returned 12.3% over the past year.
Return vs Market: 1SAN underperformed the Italian Market which returned 25.2% over the past year.
Price Volatility
1SAN volatility | |
---|---|
1SAN Average Weekly Movement | 3.3% |
Pharmaceuticals Industry Average Movement | 5.1% |
Market Average Movement | 4.2% |
10% most volatile stocks in IT Market | 7.8% |
10% least volatile stocks in IT Market | 2.6% |
Stable Share Price: 1SAN has not had significant price volatility in the past 3 months.
Volatility Over Time: 1SAN's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 86,088 | Paul Hudson | https://www.sanofi.com |
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.
Sanofi Fundamentals Summary
1SAN fundamental statistics | |
---|---|
Market cap | €114.57b |
Earnings (TTM) | €5.40b |
Revenue (TTM) | €46.03b |
21.2x
P/E Ratio2.5x
P/S RatioIs 1SAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1SAN income statement (TTM) | |
---|---|
Revenue | €46.03b |
Cost of Revenue | €14.22b |
Gross Profit | €31.82b |
Other Expenses | €26.42b |
Earnings | €5.40b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | 4.32 |
Gross Margin | 69.12% |
Net Profit Margin | 11.73% |
Debt/Equity Ratio | 22.0% |
How did 1SAN perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield87%
Payout RatioDoes 1SAN pay a reliable dividends?
See 1SAN dividend history and benchmarksSanofi dividend dates | |
---|---|
Ex Dividend Date | May 13 2024 |
Dividend Pay Date | May 15 2024 |
Days until Ex dividend | 45 days |
Days until Dividend pay date | 47 days |
Does 1SAN pay a reliable dividends?
See 1SAN dividend history and benchmarks